Minghui Pharmaceutical Presents Phase 1/2 Clinical Data of MHB088C (B7-H3 ADC) as Monotherapy for the Treatment of Patients with Recurrent or Metastatic Solid Tumors at the 2024 ASCO Annual Meeting
SHANGHAI, June 3, 2024 /PRNewswire/ — Minghui Pharmaceutical, Inc., a late-stage clinical…
Silicon Motion Unveils New USB Display Interface SoC Enabling Cost-Effective Universal Docking Stations with Support for Multiple Ultra-High Definition Displays.
The SM770 supports up to three 4K 60Hz UHD displays and up to…